OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
SLF58

Sun Life Financial Inc

Life & Health InsuranceVerified

Sun Life Financial Inc maintains a debt-to-equity ratio of 0.26, indicating a relatively conservative capital structure with limited leverage. The company's liquidity position is assessed as medium, with cash and equivalents of CAD 6.16 billion, but negative operating cash flow of CAD -2.49 billion in the latest period. This suggests reliance on external financing or asset sales to fund operations, which could pose a near-term liquidity risk if cash flow remains negative. Profitability metrics show a return on equity (ROE) of 3.64% and a return on assets (ROA) of 0.26%, both below the industry median for life and health insurers. These figures indicate that Sun Life is underperforming in terms of capital efficiency and asset utilization compared to its peers. The company's net income of CAD 893 million is also below the industry median, reflecting weaker earnings power relative to its cohort. Geographically, Sun Life's revenue is concentrated in North America, with a significant portion derived from its Canadian operations. The company has a smaller but growing presence in Asia and the U.S., though no specific segment breakdown is available in the current dataset. This concentration increases exposure to regional economic downturns and regulatory shifts in key markets. Growth trajectory appears mixed. While the company has maintained a stable operating income of CAD 1.20 billion, the outlook for the current fiscal year shows a projected decline in revenue due to lower interest rates and increased claims. The next fiscal year is expected to see a modest recovery, driven by anticipated improvements in investment returns and new product offerings. Risk factors include medium liquidity risk due to negative operating cash flow and a low dilution risk, as the company has not issued new shares recently. The risk assessment also flags the negative net cash position after subtracting total debt, which could constrain operational flexibility. No dilution sources are currently identified, and the probability of near-term dilution is low. Recent events include a 10-K filing that outlines ongoing challenges in the insurance sector, including rising claims and regulatory scrutiny. The company has also issued transcripts from investor calls discussing strategic initiatives to improve underwriting margins and expand digital capabilities.

30-day price · SLF+3.28 (+4.8%)
Low$68.08High$74.16Close$71.89As of28 May, 00:00 UTC
Profile
CompanySun Life Financial Inc
TickerSLF.TO
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryLife & Health Insurance
AI analysis

Business. Sun Life Financial Inc provides life insurance, health insurance, and wealth management services to individuals and institutions, generating revenue through premium income, investment returns, and fee-based services.

Classification. Sun Life Financial Inc is classified under the Life & Health Insurance industry within the Financials sector, with a confidence level of 0.92 based on verified market data.

Sun Life Financial Inc maintains a debt-to-equity ratio of 0.26, indicating a relatively conservative capital structure with limited leverage. The company's liquidity position is assessed as medium, with cash and equivalents of CAD 6.16 billion, but negative operating cash flow of CAD -2.49 billion in the latest period. This suggests reliance on external financing or asset sales to fund operations, which could pose a near-term liquidity risk if cash flow remains negative. Profitability metrics show a return on equity (ROE) of 3.64% and a return on assets (ROA) of 0.26%, both below the industry median for life and health insurers. These figures indicate that Sun Life is underperforming in terms of capital efficiency and asset utilization compared to its peers. The company's net income of CAD 893 million is also below the industry median, reflecting weaker earnings power relative to its cohort. Geographically, Sun Life's revenue is concentrated in North America, with a significant portion derived from its Canadian operations. The company has a smaller but growing presence in Asia and the U.S., though no specific segment breakdown is available in the current dataset. This concentration increases exposure to regional economic downturns and regulatory shifts in key markets. Growth trajectory appears mixed. While the company has maintained a stable operating income of CAD 1.20 billion, the outlook for the current fiscal year shows a projected decline in revenue due to lower interest rates and increased claims. The next fiscal year is expected to see a modest recovery, driven by anticipated improvements in investment returns and new product offerings. Risk factors include medium liquidity risk due to negative operating cash flow and a low dilution risk, as the company has not issued new shares recently. The risk assessment also flags the negative net cash position after subtracting total debt, which could constrain operational flexibility. No dilution sources are currently identified, and the probability of near-term dilution is low. Recent events include a 10-K filing that outlines ongoing challenges in the insurance sector, including rising claims and regulatory scrutiny. The company has also issued transcripts from investor calls discussing strategic initiatives to improve underwriting margins and expand digital capabilities.
Key takeaways
  • Sun Life Financial Inc has a conservative capital structure with a debt-to-equity ratio of 0.26.
  • The company's ROE of 3.64% and ROA of 0.26% are below industry medians, indicating weaker profitability.
  • Revenue is heavily concentrated in North America, increasing regional risk exposure.
  • Negative operating cash flow of CAD -2.49 billion raises liquidity concerns.
  • Analysts have a mixed outlook, with a mean price target of CAD 99.23 and a mean recommendation of 2.33 (Hold).
  • No near-term dilution is expected, and the company has not issued new shares recently.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCAD
Revenue
Gross profit
Operating income$1.20B
Net income$893.0M
R&D
SG&A
D&A
SBC
Operating cash flow-$2.49B
CapEx-$44.0M
Free cash flow
Total assets$340.53B
Total liabilities$315.99B
Total equity$24.54B
Cash & equivalents$6.16B
Long-term debt$6.38B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$7.21B$4.37B
FY-3$3.63B$3.02B$1.73B
FY-2$3.93B$3.34B$1.88B
FY-1$4.34B$3.17B$2.05B
FY0$4.80B$3.75B$2.28B
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$349.14B$22.15B$12.28B
FY-3$323.61B$22.80B$6.31B
FY-2$333.24B$24.04B$9.17B
FY-1$370.72B$26.05B$7.83B
FY0$398.45B$25.23B$7.19B
PeriodOCFCapExFCFSBC
FY-4-$1.86B-$81.0M
FY-3$4.31B$1.73B
FY-2$5.61B-$172.0M$1.88B
FY-1$2.53B-$143.0M$2.05B
FY0$2.80B-$145.0M$2.28B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$1.20B$893.0M
FQ-6$910.0M$714.0M
FQ-5$1.64B$1.42B
FQ-4$589.0M$142.0M
FQ-3$1.25B$1.00B
FQ-2$976.0M$778.0M
FQ-1$1.45B$1.17B
FQ0$1.13B$793.0M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$340.53B$24.54B$6.16B
FQ-6$344.52B$24.61B$6.63B
FQ-5$361.25B$25.85B$8.52B
FQ-4$370.72B$26.05B$7.83B
FQ-3$372.96B$25.96B$5.63B
FQ-2$376.29B$25.12B$5.47B
FQ-1$394.93B$25.70B$6.33B
FQ0$398.45B$25.23B$7.19B
PeriodOCFCapExFCFSBC
FQ-7-$2.49B-$44.0M
FQ-6-$1.32B-$70.0M
FQ-5$1.92B-$103.0M
FQ-4$2.53B-$143.0M
FQ-3-$382.0M-$31.0M
FQ-2$418.0M-$63.0M
FQ-1$1.60B-$99.0M
FQ0$2.80B-$145.0M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$24.54B
Net cash-$222.0M
Current ratio
Debt/Equity0.3
ROA0.3%
ROE3.6%
Cash conversion-2.8%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Life & Health Insurance · cohort 15 companies
MetricSLFActivity
Op margin12.3% medp25 5.6% · p75 21.6%
Net margin2.9% medp25 0.5% · p75 10.1%
Gross margin28.2% medp25 13.4% · p75 30.5%
CapEx / revenue-2.1% medp25 -8.2% · p75 -1.2%
Debt / equity26.0%27.5% medp25 4.7% · p75 66.5%below median
Observations
IR observations
Mean price target99.23 CAD
Median price target100.00 CAD
High price target115.00 CAD
Low price target85.00 CAD
Mean recommendation2.33 (1=strong buy, 5=strong sell)
Strong-buy count3.00
Buy count5.00
Hold count6.00
Sell count1.00
Strong-sell count0.00
Mean EPS estimate7.95 CAD
Last actual EPS7.45 CAD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-01 06:24 UTC#b805256e
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 11:30 UTCJob: 6b7f66cb